NCT05037175 (CPT-TEXT) is a NA clinical trial of CPT-Text in Posttraumatic Stress Disorder, sponsored by Stanford University.

Who is sponsoring NCT05037175?

NCT05037175 is sponsored by Stanford University.

What drugs are being tested in NCT05037175?

Interventions in NCT05037175: CPT-Text, Culturally Informed Trauma Treatment (CITT), Retention Incentive, Reminder as Usual.

What condition does NCT05037175 study?

NCT05037175 studies Posttraumatic Stress Disorder.

Is NCT05037175 still recruiting?

NCT05037175 is currently active, enrolled. Last updated 28 August 2025.

Last reviewed 2025-08-28 · How we verify

NCT05037175: CPT-TEXT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSD

Active, enrolled NA Last updated 28 August 2025

What this trial tests

NA trial testing CPT-Text in Posttraumatic Stress Disorder in 360 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

22 March 2022

Primary endpoint
1 October 2025

29 June 2026

Quick facts

Lead sponsor	Stanford University
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	360
Start date	22 March 2022
Primary completion	1 October 2025
Estimated completion	29 June 2026
Sites	3 locations across United States

Drugs / interventions tested

CPT-Text
Culturally Informed Trauma Treatment (CITT)
Retention Incentive
Reminder as Usual

Conditions studied

Posttraumatic Stress Disorder — all drugs for Posttraumatic Stress Disorder →

Sponsor

Stanford University

Who can join

18 and older, any sex, with Posttraumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is a pressing need to increase capacity to treat PTSD related to or exacerbated by the COVID-19 pandemic. Texting-based therapy holds promise to increase capacity and reduce barriers to delivering evidence-based treatments (EBTs), but ongoing engagement in digital mental health interventions is low. This study will compare a texting-based EBT for PTSD to culturally-informed texting-based treatment for PTSD as usual, and it will also compare a unique incentive strategy to typical platform reminders aimed to prevent early discontinuation in therapy. This online study is open to individuals who live in 18 different states.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Psychometric properties of the Oppression-Based Traumatic Stress Inventory and measurement equivalence across PTSD treatment and diverse undergraduate samples.
Holmes SC, Hoffman L, Himi D, Pica SV, et al · · 2026 · PMID 41569537 · DOI 10.1037/tra0002102
Evaluating effectiveness and engagement strategies for asynchronous, messaging, trauma-focused therapy for posttraumatic stress disorder: Study design and methodology for a hybrid effectiveness-implementation randomized controlled trial.
Dondanville KA, Calloway A, Stade EC, Hull TD, et al · · 2026 · PMID 41270826 · DOI 10.1016/j.cct.2025.108149

Verify or expand the search:

Other Stanford University trials

Trials by the same sponsor.

NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05037175 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stanford University
Last refreshed: 28 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05037175.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing